latest update:
[TrialBase DB]

trial summary · NCT07700927

Sola2 AMF Knee System Added to Surgery and Antibiotics in Adults With Knee Implant Infection

Acute Management of PJI With Local Implant Retention and Antibiotics Using the Sola2 AMF Knee System: A Multicenter Double-blind Clinical Trial.

Trial record from the TrialBase DB dataset, status RECRUITING, condition Prosthetic Joint Infection of Knee, sponsored by Solenic Medical, Inc.. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07700927phase —enrollment 165start 2026-10-30

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The goal of this clinical trial is to learn whether the Sola2 AMF Knee System, when added to surgery and antibiotic treatment, can safely improve outcomes, knee function, and quality of life in adults with knee implant infection. The main questions this study aims to answer are: 1. Whether adding the Sola2 AMF Knee System improves knee function and quality of life at 6 months. 2. Whether adding the Sola2 AMF Knee System to surgery and antibiotic treatment affects the need for additional infection-related surgery. 3. Whether the Sola2 AMF Knee System can be used safely, based on device-related adverse events through 12 months. This study has two stages. In Stage 1, participants will be enrolled into sequential sentinel groups at increasing AMF temperature levels. All sentinel participants will receive active Sola2 AMF treatment. A safety review will occur after each sentinel group before proceeding to the next group. In Stage 2, researchers will compare participants who receive active Sola2 AMF treatment to participants who receive sham AMF treatment. All participants will receive surgery called debridement, antibiotics, and implant retention (DAIR), and antibiotic treatment for knee implant infection. Participants will: * Have DAIR surgery for knee implant infection; * Receive pathogen-appropriate antibiotic treatment from the study doctor; * If enrolled in Stage 1, receive active Sola2 AMF treatment at the designated sentinel temperature level; * If enrolled in Stage 2, receive either active Sola2 AMF treatment or sham AMF treatment, depending on randomization assignment …

Source record: https://clinicaltrials.gov/study/NCT07700927

Facts

registry idNCT07700927
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionProsthetic Joint Infection of Knee
sponsorSolenic Medical, Inc.
sponsor classINDUSTRY
enrollment165
start date2026-10-30
primary completion2028-08
completion2029-08
results postednot reported

Conditions

  • Prosthetic Joint Infection of Knee

Interventions

  • Intervention 1: Alternating Magnetic Field Treatment
  • Intervention 2 - Sham Treatment
  • Debridement, Antibiotics, Implant Retention

Countries

  • United States

Intervention types: DEVICE, PROCEDURE

Work with this record